Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ann S. M. Harada"'
Autor:
Ann S. M. Harada, Scott D. Ramsey, Armen Zakharyan, Lisa Le, Soo Borson, Karen M. Stockl, Bradford S. Curtis, Sara C. Erickson
Publikováno v:
Journal of the American Geriatrics Society. 60:474-479
Objectives To examine the association between atypical antipsychotic medications and incident treatment for diabetes mellitus or hyperlipidemia in elderly adults without diagnoses of schizophrenia or bipolar disorder. Design Two case–control studie
Autor:
Brian K. Solow, Bradford S. Curtis, Scott D. Ramsey, Sara C. Erickson, Lisa Le, Armen Zakharyan, Karen M. Stockl, Ann S. M. Harada
Publikováno v:
Epilepsia. 52:1365-1371
SUMMARY Purpose: To determine if switching from select branded to generic equivalent antiepileptic drugs (AEDs) in patients with epilepsy is associated with adverse outcomes. Methods: A retrospective cohort study using a large health insurance plan c
Autor:
Bradford S. Curtis, Karen M. Stockl, Armen Zakharyan, Brian K. Solow, Lihua Zhang, Ann S. M. Harada
Publikováno v:
Journal of Medical Economics. 14:562-567
To examine medication adherence among Medicare Part D beneficiaries initiating oral anti-diabetic medications and explore whether there is any association of using mail-order pharmacy (vs. retail pharmacy) with better adherence in this patient popula
Autor:
Heidi C. Lew, Karen M. Stockl, Armen Zakharyan, Ann S. M. Harada, Brian K. Solow, Bradford S. Curtis, Jennifer S. Shin
Publikováno v:
Journal of Managed Care Pharmacy. 16:593-604
BACKGROUND: A national pharmacy benefits management company implemented a rheumatoid arthritis (RA) disease therapy management (DTM) program as an enhanced offering to patients receiving specialty pharmacy services. The program was designed to improv
Publikováno v:
Pharmacoepidemiology and Drug Safety. 18:166-174
Purpose Controversy surrounds the question whether thiazolidinediones (TZDs) increase the risk of acute myocardial infarction (AMI). This study examined risk of AMI in patients with type 2 diabetes mellitus (T2DM) who were taking TZDs or other antidi
Publikováno v:
Journal of Managed Care Pharmacy. 14:532-540
BACKGROUND: The cardiovascular (CV) benefits of lipid-lowering therapy in older adults with hypercholesterolemia and underlying risk factors for coronary artery disease (CAD) have been well documented. Significant reductions in the risk of myocardial
Acute and Continuation Treatment Adequacy with Venlafaxine Extended Release Compared with Fluoxetine
Autor:
George J. Wan, Kristina S. Yu-Isenberg, Ann S. M. Harada, Christina L. Fontes, Erika C. Geissler
Publikováno v:
Pharmacotherapy. 24:33-40
Study Objective. To compare treatment adequacy in the management of depression during the acute and continuation phases between patients newly treated with venlafaxine extended release (XR) and those newly treated with fluoxetine. Design. Retrospecti
Autor:
Sara C, Erickson, Lisa, Le, Scott D, Ramsey, Brian K, Solow, Armen, Zakharyan, Karen M, Stockl, Ann S M, Harada, Bradford, Curtis
Publikováno v:
Epilepsia. 52(7)
To determine if switching from select branded to generic equivalent antiepileptic drugs (AEDs) in patients with epilepsy is associated with adverse outcomes.A retrospective cohort study using a large health insurance plan claims database comparing pa
Publikováno v:
Pharmacoepidemiology and drug safety. 18(2)
Controversy surrounds the question whether thiazolidinediones (TZDs) increase the risk of acute myocardial infarction (AMI). This study examined risk of AMI in patients with type 2 diabetes mellitus (T2DM) who were taking TZDs or other antidiabetic m
Autor:
L. Zhang, Brian K. Solow, Armen Zakharyan, Ann S. M. Harada, Bradford S. Curtis, Karen M. Stockl
Publikováno v:
Value in Health. 14(3):A97-A98